Cancer Research Institute Defies Uncertainty with Record $34.4 Million in Grants, Propelling Innovation in Immunotherapy
admin In a fiscal year marked by significant headwinds for scientific research, the Cancer Research Institute...
Immunotherapy & CAR-T Research
Honoring a Legacy: The Victoria Ann Michelis Fund Propels Innovative Ovarian Cancer Research and Philanthropy
Rob Malone, a contributing author and close friend, is channeling the indomitable spirit and profound...
A Legacy Forged in Compassion: The Victoria Ann Michelis Fund Propels Innovative Ovarian Cancer Research and Broader Philanthropy
The enduring spirit of Victoria "Vicky" Ann Michelis, a woman who steadfastly refused to be...
Victoria Ann Michelis Fund Honors a Life of Advocacy by Advancing Ovarian Cancer Research
The indelible spirit of Victoria Ann Michelis, known affectionately as Vicky, continues to champion the...
Cancer Research Institute Defies Funding Uncertainty with Record $34.4 Million Investment, Igniting Future Discoveries and Nurturing Scientific Talent
In a fiscal year marked by widespread funding cuts and an increasingly precarious environment for...
Revolutionizing Cancer Care: The Cancer Research Institute Launches Major Initiative on Prevention and Interception
The Cancer Research Institute (CRI) has announced a groundbreaking shift in its funding strategy, dedicating...
Meet the 2026 STARs: Julie Deutsch, MD
The landscape of cancer treatment is undergoing a profound transformation, shifting from a generalized approach...
Navigating Fertility After CAR T-Cell Therapy: A Critical Inquiry into Survivorship Care
The landscape of cancer treatment has undergone a profound transformation, with innovative therapies offering unprecedented...
The Rudensky Symposium: A Landmark Convergence of Immunology, Mentorship, and the Future of Cancer Research
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
Cancer Research Institute Defies Funding Headwinds with Record $34.4 Million Investment in Pioneering Cancer Immunotherapy Research
In a fiscal year marked by pervasive uncertainty and significant funding cuts across the national...
